Retailleau Pascal, Colloc'h Nathalie, Vivarès Denis, Bonneté Françoise, Castro Bertrand, El-Hajji Mohamed, Mornon Jean Paul, Monard Gérald, Prangé Thierry
LURE, Centre Universitaire Paris-Sud, Bâtiment 209D, BP 34, 91898 Orsay CEDEX, France.
Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):453-62. doi: 10.1107/S0907444903029718. Epub 2004 Feb 25.
High-resolution X-ray structures of the complexes of Aspergillus flavus urate oxidase (Uox) with three inhibitors, 8-azaxanthin (AZA), 9-methyl uric acid (MUA) and oxonic acid (OXC), were determined in an orthorhombic space group (I222). In addition, the ligand-free enzyme was also crystallized in a monoclinic form (P2(1)) and its structure determined. Higher accuracy in the three new enzyme-inhibitor complex structures (Uox-AZA, Uox-MUA and Uox-OXC) with respect to the previously determined structure of Uox-AZA (PDB code 1uox) leads to a reversed position of the inhibitor in the active site of the enzyme. The corrected anchoring of the substrate (uric acid) allows an improvement in the understanding of the enzymatic mechanism of urate oxidase.
测定了黄曲霉尿酸氧化酶(Uox)与三种抑制剂8-氮杂黄嘌呤(AZA)、9-甲基尿酸(MUA)和氧肟酸(OXC)形成的复合物在正交空间群(I222)中的高分辨率X射线结构。此外,无配体的酶也以单斜晶形式(P2(1))结晶并确定了其结构。与先前确定的Uox-AZA结构(PDB代码1uox)相比,三种新的酶-抑制剂复合物结构(Uox-AZA、Uox-MUA和Uox-OXC)具有更高的准确性,导致抑制剂在酶活性位点中的位置发生了反转。底物(尿酸)的正确锚定有助于更好地理解尿酸氧化酶的酶促机制。